Experts red-flag cancer drug price cuts as patented therapies see zero relief, markups exceed benchmark

Mint - Oct 29, 2026

Experts said there should be comprehensive, cost-based price controls covering all oncology therapies, permanent statutory margin caps across distribution channels and full scrutiny of company assistance programmes.

Read full article

More News

Central News Today

Central News Today breaks down complex issues with unique perspective, bringing high-quality journalism to millions of readers around the world.

NEWSLETTER